MHMonash Hub

Units / BMS5007

BMS5007 · Biotechnology: Commercialising biomedical science

Official Handbook

2026 Handbook6 credit pointsLevel 5School of Biomedical Sciences

Last checked: 23 Aug 2026 UTC

Overview

This unit will examine case studies of medical biotechnology research and development, and will consider the industry context in which biotechnology is commercialised including: industry structure and competition; methods of financing, management approaches; the regulatory environment; product development and its commercial protection via intellectual property; and taking the product to market. You will examine case studies to analyse and evaluate the chances of commercialisation success of Australian companies in various phases of development, and present and justify their opinions in the form of class discussions, oral presentations and written business reports.

Offerings

CampusTeaching periodMode
ClaytonFirst semesterTeaching activities are on-campus (ON-CAMPUS)
ClaytonSecond semesterTeaching activities are on-campus (ON-CAMPUS)
Suzhou (SEU)First semesterTeaching activities are on-campus (ON-CAMPUS)

Assessment

The Handbook does not list a final examination among the assessment items. That is not a guarantee there is none.

#AssessmentTypeWeightHurdle
12 x Case study reports (4,500 words total)Demonstration55%
2In-class worksheets (1000 words) Exercise30%
3Group oral presentation (15 minutes per group)Presentation10%
4Participation in workshop / class discussionsExercise5%

Assessment details may change. Please refer to the assessment information in Moodle closer to the start of the teaching period.

Requisites

The Handbook lists no prerequisite, corequisite or prohibition for this unit.

Learning outcomes

  1. Interpret and critically evaluate the pathways from discovery science that lead to innovation and commercialisation of biotechnology innovations;
  2. Analyse and evaluate the critical role of intellectual property in the commercialisation of biotechnology;
  3. Apply advanced knowledge of how the major regulatory bodies [e.g. TGA (Therapeutic Goods Administration); FDA (Food & Drug Administration); CTN (Clinical Trial Notification Scheme)] deal with specific innovations in the biotech / medtech sectors;
  4. Evaluate and critically assess and predict the potential for commercial development and success of a specific biotechnology innovation;
  5. Systematically build and validate arguments and opinions by sourcing and critically deconstructing relevant material and information, working both independently and as part of a team;
  6. Effectively communicate complex concepts on scientific content and business processes in written or oral formats.

Workload

On-campus: 4-5 hours of contact per week, which will include a mix of presentations from industry experts and workshop activities. Off campus: a minimum of 7-8 hours of private study, including preparation of work for discussion and assessment.

ActivityDuration
Workshops72 hours

Ask about BMS5007

Answered from the Handbook fields above — no AI, no guessing. Every answer links back to the source.

Community discussions about BMS5007

Community

Student experience, not official rules. Nothing here changes what the Handbook says.

No discussions yet

Be the first to share what this unit was actually like.

Monash HubAn independent student platform

Monash Hub is an independent student information platform and is not affiliated with or endorsed by Monash University. Always confirm enrolment, graduation, visa and academic policy decisions through the Monash website, Handbook, Moodle or WES.